These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34571454)

  • 1. Baseline lung allograft dysfunction in primary graft dysfunction survivors after lung transplantation.
    Li D; Weinkauf J; Kapasi A; Hirji A; Varughese R; Lien D; Nagendran J; Halloran K
    Respir Med; 2021 Nov; 188():106617. PubMed ID: 34571454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atelectasis in primary graft dysfunction survivors after lung transplantation.
    Li D; Abele J; Weinkauf J; Kapasi A; Hirji A; Varughese R; Nagendran J; Lien D; Doucette K; Halloran K
    Clin Transplant; 2021 Jul; 35(7):e14315. PubMed ID: 33848359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline lung allograft dysfunction is associated with impaired survival after double-lung transplantation.
    Liu J; Jackson K; Weinkauf J; Kapasi A; Hirji A; Meyer S; Mullen J; Nagendran J; Lien D; Halloran K
    J Heart Lung Transplant; 2018 Jul; 37(7):895-902. PubMed ID: 29602706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary graft dysfunction grade 3 following pediatric lung transplantation is associated with chronic lung allograft dysfunction.
    Wong W; Johnson B; Cheng PC; Josephson MB; Maeda K; Berg RA; Kawut SM; Harhay MO; Goldfarb SB; Yehya N; Himebauch AS
    J Heart Lung Transplant; 2023 May; 42(5):669-678. PubMed ID: 36639317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD).
    Keller M; Bush E; Diamond JM; Shah P; Matthew J; Brown AW; Sun J; Timofte I; Kong H; Tunc I; Luikart H; Iacono A; Nathan SD; Khush KK; Orens J; Jang M; Agbor-Enoh S
    J Heart Lung Transplant; 2021 Jun; 40(6):488-493. PubMed ID: 33814284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
    Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
    J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azithromycin prophylaxis after lung transplantation is associated with improved overall survival.
    Li D; Duan Q; Weinkauf J; Kapasi A; Varughese R; Hirji A; Lien D; Meyer S; Laing B; Nagendran J; Halloran K
    J Heart Lung Transplant; 2020 Dec; 39(12):1426-1434. PubMed ID: 33041181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Airway oscillometry parameters in baseline lung allograft dysfunction: Associations from a multicenter study.
    Darley DR; Nilsen K; Vazirani J; Borg BM; Levvey B; Snell G; Plit ML; Tonga KO
    J Heart Lung Transplant; 2023 Jun; 42(6):767-777. PubMed ID: 36681528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recipient Comorbidities for Prediction of Primary Graft Dysfunction, Chronic Allograft Dysfunction and Survival After Lung Transplantation.
    Ehrsam JP; Schuurmans MM; Laager M; Opitz I; Inci I
    Transpl Int; 2022; 35():10451. PubMed ID: 35845547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction.
    Leuschner G; Lauseker M; Howanietz AS; Milger K; Veit T; Munker D; Schneider C; Weig T; Michel S; Barton J; Meiser B; Dinkel J; Neurohr C; Behr J; Kneidinger N
    J Heart Lung Transplant; 2020 Nov; 39(11):1270-1278. PubMed ID: 32917480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of right ventricular function on the development of primary graft dysfunction after lung transplantation.
    Pérez-Terán P; Roca O; Rodríguez-Palomares J; Sacanell J; Leal S; Solé J; Rochera MI; Román A; Ruiz-Rodríguez JC; Gea J; Evangelista A; Masclans JR
    J Heart Lung Transplant; 2015 Nov; 34(11):1423-9. PubMed ID: 26169669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-free DNA in human ex vivo lung perfusate as a potential biomarker to predict the risk of primary graft dysfunction in lung transplantation.
    Kanou T; Nakahira K; Choi AM; Yeung JC; Cypel M; Liu M; Keshavjee S
    J Thorac Cardiovasc Surg; 2021 Aug; 162(2):490-499.e2. PubMed ID: 32928548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal one-year post-lung transplant spirometry is a significant predictor of increased mortality and chronic lung allograft dysfunction.
    Paraskeva MA; Borg BM; Paul E; Fuller J; Westall GP; Snell GI
    J Heart Lung Transplant; 2021 Dec; 40(12):1649-1657. PubMed ID: 34548197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated pre-transplant left ventricular end-diastolic pressure increases primary graft dysfunction risk in double lung transplant recipients.
    Li D; Weinkauf J; Hirji A; Kapasi A; Lien D; Nagendran J; Kim D; Ezekowitz J; Halloran K
    J Heart Lung Transplant; 2019 Jul; 38(7):710-718. PubMed ID: 30850154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung size mismatch and primary graft dysfunction after bilateral lung transplantation.
    Eberlein M; Reed RM; Bolukbas S; Diamond JM; Wille KM; Orens JB; Brower RG; Christie JD;
    J Heart Lung Transplant; 2015 Feb; 34(2):233-40. PubMed ID: 25447586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short airway telomeres are associated with primary graft dysfunction and chronic lung allograft dysfunction.
    Greenland JR; Guo R; Lee S; Tran L; Kapse B; Kukreja J; Hays SR; Golden JA; Calabrese DR; Singer JP; Wolters PJ
    J Heart Lung Transplant; 2023 Dec; 42(12):1700-1709. PubMed ID: 37648073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung Allograft Epithelium DNA Methylation Age Is Associated With Graft Chronologic Age and Primary Graft Dysfunction.
    Dugger DT; Calabrese DR; Gao Y; Deiter F; Tsao T; Maheshwari J; Hays SR; Leard L; Kleinhenz ME; Shah R; Golden J; Kukreja J; Gordon ED; Singer JP; Greenland JR
    Front Immunol; 2021; 12():704172. PubMed ID: 34691018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease.
    Keller MB; Newman D; Alnababteh M; Ponor L; Shah P; Mathew J; Kong H; Andargie T; Park W; Charya A; Luikart H; Aryal S; Nathan SD; Orens JB; Khush KK; Jang M; Agbor-Enoh S
    J Heart Lung Transplant; 2024 Sep; 43(9):1374-1382. PubMed ID: 38705500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Survival Following Primary Graft Dysfunction Development in Lung Transplantation.
    Gouchoe DA; Whitson BA; Rosenheck J; Henn MC; Mokadam NA; Ramsammy V; Kirkby S; Nunley D; Ganapathi AM
    J Surg Res; 2024 Apr; 296():47-55. PubMed ID: 38219506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction.
    Todd JL; Jain R; Pavlisko EN; Finlen Copeland CA; Reynolds JM; Snyder LD; Palmer SM
    Am J Respir Crit Care Med; 2014 Jan; 189(2):159-66. PubMed ID: 24325429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.